Genetic regulation of embryonic head mesenchyme patterning
Genetic regulation of embryonic head mesenchyme patterning
批准号:
9290041
负责人:
Juhee Jeong
金额:
$37.64万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-04-01 至 2022-01-31
关键词:
AffectAgeApicalBirthBone platesBrainCalvariaCellsChIP-seqCompetenceCongenital AbnormalityCraniosynostosisDataDefectDermisDevelopmentDiagnosisEmbryoEmbryonic DevelopmentEquilibriumEyeFailureFrequenciesFrontal bone structureGenesGeneticGoalsHeadHeterotopic OssificationHomeoboxHumanInterventionJointsKnowledgeLateralLeadLinkLocationLong-Term EffectsMesenchymeMesodermMessenger RNAMethodsMolecularMolecular GeneticsMorbidity - disease rateMusNeural CrestOperative Surgical ProceduresOsteogenesisOutcomeParietal bone structurePathogenesisPatternPhysiologic OssificationPositioning AttributePregnancyPreventionPrimary Cell CulturesPrimordiumPublic HealthRefractoryRegulationRegulatory ElementRepressionResearchRiskSideSignal TransductionSpecificitySurgical suturesTimeWNT Signaling Pathwaybasebonecell typecraniumdeep sequencinggenome-wideimprovedimproved outcomeinnovationinsightmortalitymutantnovelorofacial developmentosteogenicoverexpressionprematurepreventprogramsregional differencesoft tissuetherapy outcometranscription factortranscriptometranscriptome sequencing
中文摘要
摘要
头盖骨(头骨的上部)由骨板和纤维关节(缝线和颧骨)组成,以及
这两个组成部分之间的平衡至关重要。颅缝融合(过早脱线(S))
出生频率为1/2000,这会导致头骨变形,进而影响大脑和口腔面部
发展。目前颅缝融合症的治疗通常涉及年轻时的侵入性手术,具有风险。
严重的发病率甚至死亡率。因此,改进对这一缺陷的干预方法是
对公众健康非常重要。我们研究的长期目标是获得全面的
了解颅骨发育的分子遗传调控,可以带来创新
治疗和预防相关出生缺陷的策略。
在胚胎发育过程中,头盖骨的头部间充质原基完全被包裹。
从早期阶段开始的大脑。随后,颅骨开始从上至下的间质发育。
位于眼睛上方的大脑外侧(眶上间充质,SOM),并逐渐向
顶点。相反,间充质从一开始就位于顶点(‘早期迁移’)。
间充质,EMM)并不启动缝合,而只对缝线等软组织起作用。
还有真皮。这种骨形成的空间限制对于形成适当图案的头盖骨至关重要。
因为它允许顶点被缝线和颧骨占据,而不是骨骼。到目前为止,人们对此知之甚少
关于头部发展计划中这种地区差异的基础因素
间充质的我。
根据我们的初步数据,我们假设EMM本质上被编程为抵抗
Lmx1b(LIM Homeobox转录因子1b)是一种关键的抗骨诱导因子。
这一背景。因此,这一建议的目的是阐明控制细胞死亡的分子机制。
以Lmx1b为中心的EMM的成骨能力。我们将定义空间和时间的特殊性
Lmx1b在颅骨发育中的作用,并探讨Lmx1b对颅骨发育的影响。
成骨信号。此外,我们将使用全基因组方法来定义特定的遗传程序
EMM和SOM,并确定Lmx1b-调节这种头部图案的下游遗传网络
间充质的我。
我们的研究结果将为颅骨早期的调节提供重要的见解。
开发并确定新的机制和参与者,这些机制和参与者可能有助于
颅骨融合症。
英文摘要
ABSTRACT
The calvaria (upper part of the skull) comprises plates of bone and fibrous joints (sutures and fontanels), and
the balance between the two components is crucial. Craniosynostosis (premature loss of suture(s)) occurs at a
frequency of 1/2000 births, and it leads to a dysmorphic skull that can further affect brain and orofacial
development. Current treatment of craniosynostosis often involves invasive surgeries at young ages, with risks
for significant morbidity and even mortality. Therefore, improving the methods of intervention for this defect is
of great importance to public health. The long-term goal of our research is to obtain comprehensive
understanding of the molecular genetic regulation of calvarial development, which can lead to innovative
strategies to treat and prevent related birth defects.
During embryonic development, the head mesenchyme primordium of the calvaria completely encases
the brain from early stages. Subsequently, the calvarial bone starts to develop from the mesenchyme on the
lateral sides of the brain just above the eye (`supra-orbital' mesenchyme, SOM), and expands gradually toward
the vertex. In contrast, the mesenchyme positioned at the vertex from the beginning (`early migrating'
mesenchyme, EMM) does not initiate ossficiation, and contributes only to the soft tissue such as the sutures
and the dermis. This spatial restriction in bone formation is crucial to making the properly patterned calvaria
because it allows the vertex to be occupied by sutures and fontanels instead of bone. To date, little is known
about the factors that underlie this regional difference in the developmental program within the head
mesenchyme.
Based on our preliminary data, we hypothesize that EMM is intrinsically programmed to resist
osteogenic induction, and that LMX1B (LIM homeobox transcription factor 1b) is a key anti-osteogenic factor in
this context. Therefore, the goal of this proposal is to elucidate the molecular mechanism controlling the
osteogenic competence of EMM with a focus on LMX1B. We will define the spatial and temporal specificity of
LMX1B function during calvarial development, and investigate the effect of LMX1B on the function of
osteogenic signals. Furthermore, we will use genome-wide approaches to define the genetic programs specific
to EMM and SOM, and identify Lmx1b-downstream genetic network that regulates this patterning of the head
mesenchyme.
The outcome of our research will provide crucial insights into the regulation of early stages of calvarial
development and identify novel mechanisms and players that can contribute to the pathogenesis of
craniosynostosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic regulation of embryonic head mesenchyme patterning
-
批准号:10228817
-
项目类别:
-
资助金额:$24.54万
-
财政年份:2017
-
负责人:Juhee Jeong
-
依托单位:
ROLE OF LDB1-LMX1B TRANSCRIPTION FACTOR COMPLEX IN CALVARIA DEVELOPMENT
-
批准号:8880178
-
项目类别:
-
资助金额:$11.89万
-
财政年份:2014
-
负责人:Juhee Jeong
-
依托单位:
Function and regulation of Lhx genes in craniofacial development
-
批准号:8201692
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2010
-
负责人:Juhee Jeong
-
依托单位:
Function and regulation of Lhx genes in craniofacial development
-
批准号:8383060
-
项目类别:
-
资助金额:$23.23万
-
财政年份:2010
-
负责人:Juhee Jeong
-
依托单位:
Function and regulation of Lhx genes in craniofacial development
-
批准号:8209195
-
项目类别:
-
资助金额:$24.65万
-
财政年份:2010
-
负责人:Juhee Jeong
-
依托单位:
Function and regulation of Lhx genes in craniofacial development
-
批准号:7571205
-
项目类别:
-
资助金额:$8.53万
-
财政年份:2009
-
负责人:Juhee Jeong
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: